BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Diagnosis
24 results:

  • 1. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations.
    Liu D; Cao M; Wang H; Cao W; Zheng C; Li Y; Wang Y
    BMC Med; 2024 Mar; 22(1):137. PubMed ID: 38528540
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Aneuploidy Landscape in Precursors of ovarian cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
    Smith P; Bradley T; Gavarró LM; Goranova T; Ennis DP; Mirza HB; De Silva D; Piskorz AM; Sauer CM; Al-Khalidi S; Funingana IG; Reinius MAV; Giannone G; Lewsley LA; Stobo J; McQueen J; Bryson G; Eldridge M; ; Macintyre G; Markowetz F; Brenton JD; McNeish IA
    Nat Commun; 2023 Jul; 14(1):4387. PubMed ID: 37474499
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
    Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
    Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adipocyte related peptides - galanin and resistin in endometrioid type endometrium cancer.
    Nergiz Avcıoğlu S; Yüksel H
    Ginekol Pol; 2022; 93(12):941-947. PubMed ID: 35072231
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Uterine serous carcinoma: key advances and novel treatment approaches.
    Ferriss JS; Erickson BK; Shih IM; Fader AN
    Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Copenhagen Index versus ROMA in preoperative ovarian malignancy risk stratification: Result from the first Vietnamese prospective cohort study.
    Tran DT; Vo VK; Le MT; Chuang L; Nguyen VQH
    Gynecol Oncol; 2021 Jul; 162(1):113-119. PubMed ID: 33994145
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
    Zhang Y; Shi X; Zhang J; Chen X; Zhang P; Liu A; Zhu T
    Sci Rep; 2021 Jan; 11(1):387. PubMed ID: 33432021
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma.
    Zhou H; Liu Q; Shi X; Liu Y; Cao D; Yang J
    J Ovarian Res; 2020 Apr; 13(1):38. PubMed ID: 32295618
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Hollis RL; Carmichael J; Meynert AM; Churchman M; Hallas-Potts A; Rye T; MacKean M; Nussey F; Semple CA; Herrington CS; Gourley C
    Am J Obstet Gynecol; 2019 Sep; 221(3):245.e1-245.e15. PubMed ID: 31055034
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Landscape of genomic alterations in high-grade serous ovarian cancer from exceptional long- and short-term survivors.
    Yang SYC; Lheureux S; Karakasis K; Burnier JV; Bruce JP; Clouthier DL; Danesh A; Quevedo R; Dowar M; Hanna Y; Li T; Lu L; Xu W; Clarke BA; Ohashi PS; Shaw PA; Pugh TJ; Oza AM
    Genome Med; 2018 Oct; 10(1):81. PubMed ID: 30382883
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prospective evaluation of IOTA logistic regression models LR1 and LR2 in comparison with subjective pattern recognition for diagnosis of ovarian cancer in an outpatient setting.
    Nunes N; Ambler G; Foo X; Widschwendter M; Jurkovic D
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):829-835. PubMed ID: 28976616
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells.
    Zhu L; Guo Q; Jin S; Feng H; Zhuang H; Liu C; Tan M; Liu J; Li X; Lin B
    Oncol Rep; 2016 Sep; 36(3):1592-604. PubMed ID: 27430660
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Marital status and survival in patients with cancer.
    Aizer AA; Chen MH; McCarthy EP; Mendu ML; Koo S; Wilhite TJ; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Hu JC; Nguyen PL
    J Clin Oncol; 2013 Nov; 31(31):3869-76. PubMed ID: 24062405
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Assessment of CA-125 area under the curve as a prognostic factor in patients with ovarian cancer.
    Uzunoglu S; Aybatlı A; Kaplan PB; Cicin I; Sut N; Sayın C; Varol F
    Med Oncol; 2013 Mar; 30(1):447. PubMed ID: 23322523
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of ovarian Malignancy Algorithm.
    Van Gorp T; Cadron I; Despierre E; Daemen A; Leunen K; Amant F; Timmerman D; De Moor B; Vergote I
    Br J Cancer; 2011 Mar; 104(5):863-70. PubMed ID: 21304524
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.